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Tumor metastases to the ureter are infrequent and are
usually diagnosed during postmortem examinations
[1,2]. Gastric cancer is an unusual primary tumor to
metastasize to the ureter [1–4]. Acute disseminated
intravascular coagulation (DIC) is a rare but severe
complication of gastric cancer, and almost all patients
die within 1–3 weeks of developing DIC [5,6]. We
report the case of a patient who developed acute DIC
after surgical resection of a metastatic ureteral tumor
derived from gastric signet ring cell carcinoma.
CASE PRESENTATION
A 66-year-old man suffered from intermittent, dull
abdominal pain in the left lower abdomen for 3 months
and was admitted to the gastroenterological surgery
department for evaluation. He had a history of subto-
tal gastrectomy for gastric cancer nearly 3 years pre-
viously, and histologic diagnosis was signet ring cell
carcinoma, stage T4N1M0. He received adjuvant che-
motherapy over several years due to the high tumor
stage. He claimed to have no recent body weight loss,
nausea, melena, bowel habit changes, or tenesmus.
Physical examination revealed mild left costoverte-
bral angle knocking pain. Results of complete blood
count and urinalysis were normal. The level of carci-
noembryonic antigen (CEA, 2.12 ng/mL) was within
normal limits. Computed tomography of the abdomen
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A 66-year-old man, with a history of gastric signet ring cell carcinoma, was admitted due to inter-
mittent dull pain in the left lower abdomen for 3 months. Left ureteral obstruction with suspicious
tumor encasement and hydronephrosis was found on imaging studies. Endoscopic ureteral biopsy
revealed infiltrating high-grade urothelial carcinoma. As a result, he underwent left nephroure-
terectomy and bladder cuff excision. Unexpectedly, metastatic carcinoma of the left ureter from
the stomach was the final diagnosis after comparison of the permanent sections of the two speci-
mens. Unfortunately, acute disseminated intravascular coagulation developed and the patient
died of disease complications 16 days after the operation, even with intensive care. The details of
this rare condition are reported herein with a review of the medical literature.
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revealed left hydronephrosis. Retrograde pyelography
failed due to the sharp angle of the distal ureter.
Antegrade pyelography showed left ureteral obstruc-
tion. Percutaneous nephrostomy and double J stent
were then placed successfully by a radiologist.
However, gross hematuria developed and urine
cytology raised a high degree of suspicion of carci-
noma. Subsequent ureteroscopy showed persistent
left ureteral obstruction after ureteral stenting for 1.5
months. Biopsy of the obstructive site was performed,
and the section showed highly pleomorphic cancer
cells infiltrating the desmoplastic ureteral muscle wall.
The pathologist interpreted the specimen as showing
high-grade infiltrating urothelial carcinoma.
As a result, the patient underwent left nephroure-
terectomy and bladder cuff excision. Severe periure-
teral adhesion and diffuse wall thickening were found
in the ureter. The clinical course of the first 5 days
after operation was smooth, as anticipated, except for
mild thrombocytopenia postoperatively (121,000cells/
mm3). However, gross hematuria occurred on the 
6th postoperative day and the platelet count dropped
to 17,000 cells/mm3. Laboratory data, including de-
creased serum fibrinogen level, positive 3P test and
increased D-dimer level, led to a diagnosis of DIC. Low
urine output, progressive shortness of breath, orthop-
nea, and lower leg edema developed shortly thereafter.
Metabolic acidosis, electrolyte imbalance, pulmonary
congestion, and acute renal failure followed, and emer-
gent hemodialysis was performed. He was transferred
to an intensive care unit, where a heparin drip was
used and intubation was performed due to respiratory
distress. Massive gastrointestinal bleeding started on
the 15th day after surgery and we were unable to re-
verse the bleeding tendency, even with continuous
administration of platelet concentrates and fresh-frozen
plasma. The patient passed away the following day
due to hypovolemic shock and subsequent pulseless
electrical activity. Unexpectedly, histopathologic exam-
ination of the specimen revealed infiltrating cancer
cells exhibiting undifferentiated signet-ring cell fea-
tures (Figure), and the final pathology report was
high-grade metastatic carcinoma.
DISCUSSION
Hemostatic abnormalities are rather common in can-
cer patients. They are recognizable in about 50% of
patients with localized tumors and in more than 90%
of patients with metastatic disease [7]. The cancers
that are most frequently associated with an increased
risk of clotting include acute leukemia [8] and solid
tumors such as carcinomas of the lung, breast, stomach,
pancreas, prostate, ovary, and colon [9–14]. A variable
percentage of cancer patients, ranging from 9% to 15%,
may develop DIC during the course of their disease
[12]. Most of these develop chronic DIC, character-
ized by few laboratory abnormalities and no hemor-
rhagic symptoms, whereas a minority of patients with
DIC have an acute course with evident laboratory
alterations and bleeding [15].
The syndrome of DIC results from injury to the
vascular endothelium. Platelets and clotting factors
are activated and consumed, leading to thrombosis
and bleeding. An unidentified procoagulant substance
from adenocarcinomas directly stimulates the coagu-
lation mechanism [16]. Surgery causes tissue injury,
exposes transmembrane glycoproteins that bind with
coagulation factors, and further enhances the devel-
opment of DIC. Recognizing DIC in the early phase
can be difficult. There is no one test or scan that can
conclusively diagnose acute DIC in a patient with
cancer [16]. Bleeding is the most obvious sign of DIC,
such as the gross hematuria in our patient.
Acute DIC as a complication of solid tumors
appears to be rather rare. Pasquini et al reported that
1.6% of the patients with solid cancers diagnosed and
followed in their institution developed acute DIC and
Figure. The ureter stained by hematoxylin and eosin shows 
cancerous cells distributed in the lamina propria and muscularis
(original magnification, 100×). The signet ring-like cell exhibits 
a large mucin vacuole that fills the cytoplasm and displaces the
nucleus (insert: magnification, 400×).
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that 0.68% of them had gastric cancers [6]. As DIC is
mainly associated with a large tumor burden or with
metastatic disease, it is difficult to manage because
effective therapy for solid tumors is lacking. Pasquini
et al [6] reported that acute DIC occurred in four
patients with gastric cancer and three with breast can-
cer. All patients died rapidly because of major hem-
orrhagic complications, except for one patient who
initially responded to blood component transfusion
and heparin therapies.
Treatment for DIC in cancer patients is essentially
based on the administration of platelets and coagula-
tion factors, but it is often not sufficient to ameliorate
the complication of acute DIC [5,6]. The basic principle
of treating cancer-associated acute DIC involves treat-
ing the underlying stimulus, that is, gaining control
of the cancer [16]. However, the critical clinical condi-
tion, severe thrombocytopenia, and the associated
bleeding tendency limit the use of myelosuppressive
chemotherapy. Nevertheless, Yeh and Cheng reported
that high-dose 5-fluorouracil and leucovorin were
effective treatment for acute DIC in gastric cancer
patients [17].
Metastases from distant primary tumors to the
ureter are rare. The primary sites of distant tumors
with ureteral metastasis are mostly the breast, colon,
prostate, and cervix [1,2]. The criterion of true ureteral
metastasis has been widely accepted to date and is as
follows: “the demonstration of malignant cells in a
portion of the ureteral wall together with the absence
of any neoplasm in adjacent tissues”.
Metastasis of gastric carcinoma to the ureter is very
rare [1–4]. In most published cases, the diagnosis is
only made at postmortem examination. There are
three types of presentation [2]. It can appear as trans-
mural/periureteral adventitial involvement with
resultant compression of the ureteral wall or local
mucosal metastasis. The first two types manifest as
stricture formation with or without an associated
mass, and the third type is seen radiographically as
one or more filling defects within the lumen [18]. The
present case fits the transmural pattern of metastasis.
In the past, pathologists have supposed that,
although histologic examination is helpful in diagno-
sis of metastatic ureteral neoplasm, often the lesion
may be extremely pleomorphic, so that histologic
examination is of little value in determining whether
the lesion is primary or secondary. In the present
case, the primary tumor was a gastric signet ring cell
carcinoma, and it is known that the urothelium has
potential for metaplastic change to primary signet
ring cell carcinoma, a phenotypic variant of transi-
tional cell carcinoma [19,20]. This further increases
the difficulty in making an accurate diagnosis. We
retrospectively reviewed the previous biopsy section
from our patient and found that the cancerous cells
were mainly located in the deeper layers, with a rela-
tively intact mucosa. Although this provides indirect
support for the existence of a secondary lesion, it
could be a result of extensive disease caused by the
primary tumor.
The largest series of gastric cancer patients was
reported in the Japanese literature. Shimoyama et al
reviewed 27 cases of gastric cancer with true ureteral
metastasis [4]. The most common symptom was back,
lumbar, flank, or abdominal pain that seemed to be
caused by hydronephrosis (81%). Poorly differenti-
ated adenocarcinoma and signet ring cell carcinoma
were the most common tumor types, and, in the major-
ity, metastasis was established via lymphatic vessels.
The diagnosis of ureteral metastasis from the stomach
was made before any surgical procedure or death in
only two patients (7%), suggesting that it is quite diffi-
cult to make a correct diagnosis early on. Most of the
patients died of the disease within 1 year, and survival
for more than 2 years has never been documented.
Notably, although acute DIC is a known complication
of gastric cancer, none of their patients who received
surgery (13/27, 48%) developed this severe compli-
cation. To our knowledge, the patient reported here
may be the first patient to develop acute DIC immedi-
ately after resection of metastatic ureter lesions from
gastric cancer.
The treatment for solitary ureteral metastasis from
gastric carcinoma is indefinite. There has been no
report describing an effective therapy for this condi-
tion. Although the prognosis of patients with metasta-
sized gastric carcinoma is poor, nephroureterectomy
for treatment and diagnosis seems to be adequate [3,4].
However, surgical resection can run counter to our
desire due to the possible development of fatal compli-
cations. Chemotherapeutic agents fail to even delay
disease progression. Therefore, palliative treatment,
such as adequate drainage of the involved kidney, is
usually advocated [1]. Percutaneous nephrostomy has
been reported to be a better procedure to preserve
renal function owing to the high failure rate of double
J stents [21].
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When facing an unusual presentation of a ureteral
tumor, we should consider the probability of metas-
tasis carefully if a malignancy has been previously
diagnosed. A biopsy ought to be obtained if feasible
and the surgeon must discuss the interpretation with
the pathologist in detail. When the metastatic nature
is confirmed, the necessity of an operation has to be
deliberated over. To prevent the development of acute
DIC, the best policy is adequate drainage by percuta-
neous nephrostomy. Once acute DIC has occurred,
high-dose 5-fluorouracil and leucovorin treatment is
the best option.
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